Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,135 | -8,931 | -6,418 | -2,338 | -12,913 |
| Depreciation Amortization | 1,624 | 1,191 | 806 | 399 | 1,251 |
| Accounts receivable | -1,105 | -628 | -661 | -419 | -594 |
| Other Working Capital | -1,942 | -414 | 354 | 11 | -555 |
| Other Operating Activity | 5,332 | 3,808 | 3,036 | 920 | 6,127 |
| Operating Cash Flow | $-7,226 | $-4,974 | $-2,883 | $-1,427 | $-6,684 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,355 | -1,701 | -1,276 | -684 | -2,835 |
| Other Investing Activity | -10 | 4 | 4 | 4 | -192 |
| Investing Cash Flow | $-2,365 | $-1,697 | $-1,272 | $-680 | $-3,027 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,402 | 10,306 | 5,985 | 3,343 | 3,417 |
| Debt Repayment | -5,772 | N/A | N/A | N/A | -796 |
| Common Stock Issued | 25,098 | 5,839 | N/A | N/A | 4,738 |
| Other Financing Activity | -1,541 | -901 | -477 | -221 | -579 |
| Financing Cash Flow | $30,187 | $15,244 | $5,508 | $3,122 | $6,780 |
| Exchange Rate Effect | 39 | 3 | -16 | -4 | -34 |
| Beginning Cash Position | 2,390 | 2,390 | 2,390 | 2,390 | 5,355 |
| End Cash Position | 23,025 | 10,966 | 3,727 | 3,401 | 2,390 |
| Net Cash Flow | $20,635 | $8,576 | $1,337 | $1,011 | $-2,965 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,226 | -4,974 | -2,883 | -1,427 | -6,684 |
| Capital Expenditure | -2,355 | -1,701 | -1,276 | -684 | -2,835 |
| Free Cash Flow | -9,581 | -6,675 | -4,159 | -2,111 | -9,519 |